Cargando…

Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors

Detalles Bibliográficos
Autores principales:	Lee, Kyoung-Hwa, Ku, Ja Hyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323290/ https://www.ncbi.nlm.nih.gov/pubmed/30687604 http://dx.doi.org/10.21037/tau.2018.10.09

Ejemplares similares

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

Where are we now and where are we heading in muscle invasive bladder cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2020)

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer
por: Tae, Bum Sik, et al.
Publicado: (2017)

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
por: Pan, Chin-Chen
Publicado: (2018)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis
por: Ko, Kyungtae, et al.
Publicado: (2017)

Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy
por: Luchini, Claudio, et al.
Publicado: (2017)

Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor
por: Kang, Minyong, et al.
Publicado: (2016)

Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
por: Kang, Minyong, et al.
Publicado: (2015)

Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance
por: Kang, Minyong, et al.
Publicado: (2016)

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Emerging role of liquid biopsy of cell-free tumor DNA for bladder cancer surveillance
por: Kang, Minyong, et al.
Publicado: (2017)

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
por: Tae, Bum Sik, et al.
Publicado: (2017)

Diagnostic and Prognostic Markers in Bladder Cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2016)

Molecular Landscape of Non-Muscle Invasive Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)

Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer
por: Kweon, Tae Dong, et al.
Publicado: (2018)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials
por: Kim, Hyung Suk, et al.
Publicado: (2017)

Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs
por: Kang, Minyong, et al.
Publicado: (2016)

Non-invasive Parameters Predicting Bladder Outlet Obstruction in Korean Men with Lower Urinary Tract Symptoms
por: Kang, Min-Yong, et al.
Publicado: (2010)

Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells
por: Kang, Minyong, et al.
Publicado: (2017)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
por: Tan, Wei Shen, et al.
Publicado: (2018)

A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?
por: Sylvester, Richard
Publicado: (2018)

Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer
por: Batura, Deepak
Publicado: (2018)

Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer
por: Lian, Jie, et al.
Publicado: (2018)

Paving the Road Towards Non-Invasive Molecular Imaging
por: Fijneman, Remond J.A.
Publicado: (2006)

Next-generation sequencing in non-muscle-invasive bladder cancer—a step towards personalized medicine for a superficial bladder tumor
por: Butterfield, Andrew, et al.
Publicado: (2017)

Clinical benefit to regionalization of care for muscle invasive bladder cancer
por: Haque, Waqar, et al.
Publicado: (2018)

Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
por: Szarvas, Tibor, et al.
Publicado: (2019)

Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
por: AZhaTi, BaiHeTiYa, et al.
Publicado: (2022)

Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study
por: Kim, Hyung Suk, et al.
Publicado: (2016)

Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score
por: Breyer, Johannes
Publicado: (2017)

Age does not matter: the relevance of immediate instillation therapy with Mitomycin C in non-muscle invasive bladder cancer
por: Christoph, Frank, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3cl4tapthlu8st8mv2tfhu4ien